Budget Impact of Publicly Reimbursed Prescription Medicines in the Republic of Srpska

Frontiers in Public Health

Tamara Petrusic¹ 

关键词: prescription medicines;    pharmaceuticals;    reimbursement;    Republic of Srpska;    Bosnia;    cost;    budget impact;    trend;   

DOI  :  10.3389/fpubh.2015.00213

学科分类：卫生学

来源: Frontiers

【 摘 要 】

Observing 5-year time horizon (2009–2013), we see that moderate growth of pharmaceutical market took place. Some ATC code groups recorded far more substantial market changes than others. Thus, systemic hormonal preparations, excluding sex hormones, and insulin value-based turnover increased for 92%, and antiparasitic products, insecticides, and repellents spending decreased for 63%. Changes were also significant in the indication field of blood and blood-forming organs reporting 36% growth, as well as antineoplastic and immunomodulating agents, sensory organs, respiratory system, and alimentary tract and metabolism drugs which increased their sales volume around 30% each. Top 10 ATC second-level code groups in 2009 and 2013 have been renin–angiotensin system agents, antibacterials for systemic use, antineoplastic agents, psycholeptics, drugs used in diabetes, drugs for acid-related disorders, analgesics, calcium channel blockers, anti-inflammatory and antirheumatic products, beta blocking agent, and antithrombotic agents. Consumption of preparations for wounds and ulcers treatment has increased three times. Nasal preparations, digestives, including enzymes, pituitary and hypothalamic hormones, and prescribing antigout preparations have also increased twofold (Table ​(Table11).

【 授权许可】

CC BY